Table 1.
Characteristic | |
---|---|
Demographic and clinical data | |
Age, y | 65.21±10.09 |
Men | 87 (79.82) |
BMI, kg/m2 | 24.96±3.31 |
Systemic hypertension | 88 (80.73) |
Smoking | 78 (71.56) |
Hyperlipidemia | 36 (33.03) |
Diabetes mellitus | 10 (9.17) |
Coronary heart disease | 37 (33.94) |
Imaging | |
Mean number of penetrating atherosclerotic ulcers | 1.15±0.40 |
Aortic arch | 33 (30.28) |
Descending thoracic aorta | 72 (66.06) |
Abdominal aorta | 4 (3.67) |
Mean ulcer diameter, mm | 11.31±5.44 |
Mean ulcer depth, mm | 8.19±4.50 |
Maximum ascending aorta diameter, mm | 43.08±4.84 |
Maximum descending aorta diameter, mm | 30.37±5.62 |
Pleural effusion | 33 (30.28) |
Pericardial effusion | 1 (0.92) |
Medical | |
Antiplatelet agents | 5 (4.59) |
Beta‐blockers | 8 (7.34) |
Calcium antagonists | 35 (32.11) |
ACE inhibitors | 5 (4.59) |
ARB inhibitors | 16 (14.68) |
Nitrates | 4 (3.67) |
Statins | 5 (4.59) |
Systolic BP, mm Hg | 150.07±24.18 |
Diastolic BP, mm Hg | 85.74±13.24 |
Heart rate, BPM | 79.01±10.46 |
Laboratory examinations | |
CKMB, ng/mL | 11.00 (8.50, 15.50) |
TNT exception | 33 (30.28) |
ALT, U/L | 16.20 (12.00, 23.30) |
AST, U/L | 18.00 (14.54, 24.01) |
WBC, 109/L | 9.97±2.72 |
PLT, 109/L | 206.00 (178.50, 253.00) |
HG, g/L | 133.09±17.43 |
BUN, mmol/L | 6.36 (4.97, 9.34) |
CR, μmol/L | 81.10 (68.60, 103.00) |
C‐reactive protein, mg/dL | 49.30 (19.50, 62.90) |
D‐dimer, ng/mL | 1.60 (0.80, 2.85) |
Data are expressed as mean±SD, medians (25th percentiles, 75th percentiles), or number (percentage). ACE indicates angiotensin‐converting enzyme; ALT, alanine aminotransferase; ARB, angiotensin receptor blocker; AST, aspartate aminotransferase; BMI, body mass index; BP, blood pressure; BPM, beat per minute; BUN, blood urea nitrogen; CKMB, creatine phosphokinase‐myocardial band; CR, creatinine; HG, hemoglobin; PLT, platelet count; TNT, troponin‐T; and WBC, white blood cell.